President Donald Trump has signed an executive order expanding federal research into psychedelic drugs and explore their use in controlled medical settings.
The order direct the Food and Drug Administration to issue new guidance for clinical trials involving substances such as psilocybin, ibogaine, LSD, and MDMA.
The podcast host Joe Rogan, who has long advocated for research into psychedelics, attended the signing ceremony.
Such drugs are currently classified as Schedule I, meaning they are considered to have no accepted medical use and a high potential for abuse.